Search Results for "Sirolimus Lambert Eaton"
Original Source: Immunotherapy of the Paraneoplastic Syndromes
We treat a subset of patients with paraneoplastic neurologic disorders, including those with Yo-mediated paraneoplastic cerebellar degeneration (PCD), the Hu syndrome, which is most commonly associated with small cell lung cancer (SCLC) - paraneoplastic subacute sensory neuropathy, encephalomyelitis, limbic encephalopathy, autonomic neuropathy - and the Ri Syndrome (a.k.a. POMA - Paraneoplastic Opsoclonus-Myoclonus Ataxia), as well as those patients suspected to have a paraneop...
Matching Channels
None
Matching News
Transplantation: Sirolimus for secondary SCC prevention in renal transplantation
A recently published study suggests that sirolimus is an attractive treatment option for the prevention of secondary skin cancer in kidney transplant recipients. However, before we think about switchi...
Edward O. Eaton, M.S. '50, Ph.D. '52, a professor emeritus of agricultural engineering, died July 11 at age 93 in St. Albans, Vt.
Sirolimus advantageous after liver transplantation for cancer
NEW YORK (Reuters Health) - Recurrent hepatoma after liver transplantation is less likely with immunosuppression protocols that include sirolimus, a meta-analysis suggests.
Everolimus more effective than sirolimus in coronary stents
NEW YORK (Reuters Health) - Mortality rates are similar, but pooled data show other advantages when coronary stents are coated with everolimus rather than sirolimus, researchers say.
Sirolimus reduces post-transplant skin cancer risk
Patients who have undergone kidney transplants are less likely to develop skin cancer when given sirolimus for immunosuppression than if they receive calcineurin inhibitors, a French study suggest...
Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into Strategic Collaboration ...
BioMarin to Make $5 Million Strategic Equity Investment in Catalyst Catalyst Licenses North American Rights to Firdapse™, a Phase III Orphan Drug for the Treatment of Lambert-Eaton Myas...
Late Switch to Sirolimus in Kidney Recipients With Skin Cancer
In kidney recipients with cutaneous invasive squamous cell carcinomas (SCCs), switching to sirolimus from conventional immunosuppression does not significantly improve disease-free survival. Reuters...
COMBO "Healing," Sirolimus-Eluting Stent Gets CE Mark
Now with the CE Mark, the stent elutes antiproliferative sirolimus but also features an anti-CD34 antibody coating to promote endothelialization, with the goal of cutting the risk of in-stent thro...
Matching PubMed Articles
There are many causes of prolonged postoperative muscle weakness, including drugs, residual anesthetics, cerebrovascular events, electrolyte imbalance, hypothermia, and neuromuscular disease. Neuromus...
Lambert-Eaton myasthenic syndrome following H1N1-influenza vaccination - a case report.
BACKGROUND: The outbreak of influenza A (H1N1) pandemic during the year 2009 led to the development of several vaccinations against H1N1 virus. In Finland, 2.6 million citizens were vaccinated during...
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
The Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disease in which antibodies against voltage-gated calcium channels inhibit cholinergic neurotransmission. LEMS is clinically characterized...
Child Neurology: Diagnosis of Lambert-Eaton myasthenic syndrome in children.
OBJECTIVE: To report a case of Lambert-Eaton myasthenic syndrome (LEMS) in a child and review the existing literature of LEMS in children. METHODS: We report a pediatric case of LEMS with the classic...
IgG Fc N-Glycosylation Changes in Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis.
N-glycosylation of the immunoglobulin Fc moiety influences its biological activity by, for example, modulating the interaction with Fc receptors. Changes in IgG glycosylation have been found to be ass...
